SCHEMBL8970834

SCHEMBL8970834

CC(C)(C)[Si](C)(C)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15863920 0.69
SCHEMBL28847957 0.69 TSHR (0.32)
SCHEMBL5683569 0.67
SCHEMBL22285870 0.67
SCHEMBL29437591 0.65
SCHEMBL28421570 0.65
SCHEMBL6912319 0.65
SCHEMBL2146831 0.64
SCHEMBL6915209 0.64
SCHEMBL1376695 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4424158-A HALOMETHYLTRIALKYLSILANE, MAGNESIUM, DIPHENYLPHORPHORIC AZIDE CHISSO CORPORATION (JP) 1984-01-03 US claimed
US-5536732-A REDUCING INFECTIOUSNESS OF HIV MERRELL PHARMACEUTICALS INC. (US) 1996-07-16 US disclosed
EP-0454580-B1 Novel nojirimycin derivatives MERRELL DOW PHARMA (US) 1995-12-27 EP disclosed
US-5252587-A Viricides, aids therapy, antidiabetic agent MERRELL DOW PHARMACEUTICALS, INC. (US) 1993-10-12 US disclosed
EP-0454580-A2 Novel nojirimycin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-30 EP disclosed
EP-0453692-A1 Novel nojirimycin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-30 EP disclosed
EP-0071440-B1 PROCESS FOR PREPARING TRIALKYLSILYLDIAZOMETHANES Chisso Corporation (JP) 1985-05-02 EP disclosed
US-4424158-A HALOMETHYLTRIALKYLSILANE, MAGNESIUM, DIPHENYLPHORPHORIC AZIDE CHISSO CORPORATION (JP) 1984-01-03 US disclosed